Dorval Allison
CIK: 0001625110•Chief Financial Officer
OfficerDirector
Primary company: Verve Therapeutics, Inc. (VERV)
Dorval Allison is a corporate insider (Chief Financial Officer) at Verve Therapeutics, Inc. (VERV) filing SEC Form 4 transactions. 57 transactions across 5 companies, totaling $0 in purchases and $237,894 in sales. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
| Sale | 11,610 | $7.20 | $84K | 90,780 | 6/12/2026 Filed: 6/11/2026 | Filing → | |
| Award | 27,000 | - | - | 102,390 | 6/11/2026 Filed: 6/11/2026 | Filing → | |
Verve Therapeutics, Inc. VERV | Disposition | 180,000 | - | - | 0 | 7/25/2025 Filed: 7/28/2025 | Filing → |
Verve Therapeutics, Inc. VERV | Disposition | 1,875 | - | - | 0 | 7/25/2025 Filed: 7/28/2025 | Filing → |
Verve Therapeutics, Inc. VERV | Disposition | 33,750 | - | - | 0 | 7/25/2025 Filed: 7/28/2025 | Filing → |
Verve Therapeutics, Inc. VERV | Disposition | 45,000 | - | - | 0 | 7/25/2025 Filed: 7/28/2025 | Filing → |
Verve Therapeutics, Inc. VERV | Disposition | 75,000 | - | - | 0 | 7/25/2025 Filed: 7/28/2025 | Filing → |
Verve Therapeutics, Inc. VERV | Disposition | 258,000 | - | - | 0 | 7/25/2025 Filed: 7/28/2025 | Filing → |
Verve Therapeutics, Inc. VERV | U | 13,280 | - | - | 0 | 7/25/2025 Filed: 7/28/2025 | Filing → |
| Sale | 11,610 | $3.40 | $39K | 75,390 | 6/13/2025 Filed: 6/17/2025 | Filing → | |
| Award | 27,000 | - | - | 87,000 | 6/11/2025 Filed: 6/13/2025 | Filing → | |
Verve Therapeutics, Inc. VERV | Sale | 3,350 | $4.15 | $14K | 13,280 | 4/2/2025 Filed: 4/3/2025 | Filing → |
Verve Therapeutics, Inc. VERV | Exercise | 11,250 | - | - | 33,750 | 4/1/2025 Filed: 4/3/2025 | Filing → |
Verve Therapeutics, Inc. VERV | Exercise | 11,250 | - | - | 16,630 | 4/1/2025 Filed: 4/3/2025 | Filing → |
Verve Therapeutics, Inc. VERV | Award | 75,000 | $6.01 | $451K | 75,000 | 1/8/2025 Filed: 1/10/2025 | Filing → |
Verve Therapeutics, Inc. VERV | Award | 45,000 | - | - | 45,000 | 1/8/2025 Filed: 1/10/2025 | Filing → |
Verve Therapeutics, Inc. VERV | Award | 258,000 | $6.01 | $1.55M | 258,000 | 1/8/2025 Filed: 1/10/2025 | Filing → |
Verve Therapeutics, Inc. VERV | Sale | 555 | $5.64 | $3K | 5,380 | 12/2/2024 Filed: 12/3/2024 | Filing → |
Verve Therapeutics, Inc. VERV | Exercise | 1,875 | - | - | 1,875 | 11/29/2024 Filed: 12/3/2024 | Filing → |
Verve Therapeutics, Inc. VERV | Exercise | 1,875 | - | - | 5,935 | 11/29/2024 Filed: 12/3/2024 | Filing → |
Type
Sale
Shares
11,610
Price
$7.20
Value
$84K
Type
Award
Shares
27,000
Price
-
Value
-
Verve Therapeutics, Inc.
VERV
Type
Disposition
Shares
180,000
Price
-
Value
-
Verve Therapeutics, Inc.
VERV
Type
Disposition
Shares
1,875
Price
-
Value
-
Verve Therapeutics, Inc.
VERV
Type
Disposition
Shares
33,750
Price
-
Value
-
Verve Therapeutics, Inc.
VERV
Type
Disposition
Shares
45,000
Price
-
Value
-
Verve Therapeutics, Inc.
VERV
Type
Disposition
Shares
75,000
Price
-
Value
-
Verve Therapeutics, Inc.
VERV
Type
Disposition
Shares
258,000
Price
-
Value
-
Verve Therapeutics, Inc.
VERV
Type
U
Shares
13,280
Price
-
Value
-
Type
Sale
Shares
11,610
Price
$3.40
Value
$39K
Type
Award
Shares
27,000
Price
-
Value
-
Verve Therapeutics, Inc.
VERV
Type
Sale
Shares
3,350
Price
$4.15
Value
$14K
Verve Therapeutics, Inc.
VERV
Type
Exercise
Shares
11,250
Price
-
Value
-
Verve Therapeutics, Inc.
VERV
Type
Exercise
Shares
11,250
Price
-
Value
-
Verve Therapeutics, Inc.
VERV
Type
Award
Shares
75,000
Price
$6.01
Value
$451K
Verve Therapeutics, Inc.
VERV
Type
Award
Shares
45,000
Price
-
Value
-
Verve Therapeutics, Inc.
VERV
Type
Award
Shares
258,000
Price
$6.01
Value
$1.55M
Verve Therapeutics, Inc.
VERV
Type
Sale
Shares
555
Price
$5.64
Value
$3K
Verve Therapeutics, Inc.
VERV
Type
Exercise
Shares
1,875
Price
-
Value
-
Verve Therapeutics, Inc.
VERV
Type
Exercise
Shares
1,875
Price
-
Value
-
AI Agent
Try asking...